Flag-HA-CYLD Citations (5)

Originally described in: Defining the human deubiquitinating enzyme interaction landscape.
Sowa ME, Bennett EJ, Gygi SP, Harper JW Cell. 2009 Jul 23. 138(2):389-403. PubMed Journal

---

Articles Citing Flag-HA-CYLD

Articles
SPATA2 promotes CYLD activity and regulates TNF-induced NF-kappaB signaling and cell death. Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, Maurer U. EMBO Rep. 2016 Oct;17(10):1485-1497. doi: 10.15252/embr.201642592. Epub 2016 Jul 25. PubMed
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors. Lei FX, Jin L, Liu XY, Lai F, Yan XG, Farrelly M, Guo ST, Zhao XH, Zhang XD. Cell Death Dis. 2018 Jun 7;9(6):679. doi: 10.1038/s41419-018-0714-7. PubMed
Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells. La T, Jin L, Liu XY, Song ZH, Farrelly M, Feng YC, Yan XG, Zhang YY, Thorne RF, Zhang XD, Teng L. Oncol Res. 2020 Sep 1;28(4):385-398. doi: 10.3727/096504020X15861709922491. Epub 2020 Apr 6. PubMed
Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma. Deng M, Dai W, Yu VZ, Tao L, Lung ML. Cancers (Basel). 2020 Jul 16;12(7). pii: cancers12071924. doi: 10.3390/cancers12071924. PubMed
NF-kappaB over-activation portends improved outcomes in HPV-associated head and neck cancer. Schrank TP, Prince AC, Sathe T, Wang X, Liu X, Alzhanov DT, Burtness B, Baldwin AS, Yarbrough WG, Issaeva N. Oncotarget. 2022 May 24;13:707-722. doi: 10.18632/oncotarget.28232. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.